FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048554033> ?p ?o ?g. }

• W3048554033 endingPage "2612" @default.
• W3048554033 startingPage "2606" @default.
• W3048554033 abstract "Abstract Background The management of chronic alopecia areata (CAA) is challenging. There is currently no therapy that produces consistent successful hair regrowth. Systemic therapies, including prednisolone and steroid‐sparing agents (SSA), are often tried in patients with CAA. As there are no head‐to‐head clinical trials that compare efficacy of one SSA over another, retrospective studies of treatment in clinical practice may help guide clinical practice. Objective To investigate the utility of SSAs in the treatment of AA. Methods An electronic medical records search identified patients with AA and those prescribed azathioprine, cyclosporine or methotrexate between 2002 and 2019. Type of AA, treatment duration, reason for cessation, use of concurrent prednisolone, dose of prednisolone and duration of prednisolone use were recorded. The primary outcome was SSA continuation rate at 6 and 12 months. Results A total of 852 AA patients were identified, among whom 138 patients had been treated with azathioprine, methotrexate or cyclosporine. Of these 138 patients treated with a SSA, 92 (66.7%) continued treatment for at least 12 months: 75.3% (55/73) of azathioprine users, 50% (11/22) of methotrexate users and 60.5% (26/43) of cyclosporine users. At 12 months, 67.3% of azathioprine users required concurrent prednisolone at a mean dose of 5.6 mg daily, 63.6% of methotrexate users required prednisolone at a mean dose of 5 mg daily and 57.7% of cyclosporine users required prednisolone at a mean dose of 8.7 mg daily. The SSA was ceased due to an adverse event in 15.9% of patients and a lack of efficacy in 17.4%. Conclusion The most well‐utilized SSA for CAA patients at our clinic was azathioprine. This study highlights that most CAA patients who commence treatment with azathioprine, methotrexate or cyclosporine continue that treatment for at least 12 months and most require concurrent low‐dose prednisolone to maintain remission or promote continued hair regrowth." @default.
• W3048554033 created "2020-08-18" @default.
• W3048554033 creator A5035044854 @default.
• W3048554033 creator A5047001800 @default.
• W3048554033 date "2020-09-01" @default.
• W3048554033 modified "2023-10-13" @default.
• W3048554033 title "Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients" @default.
• W3048554033 cites W1881722651 @default.
• W3048554033 cites W1965964672 @default.
• W3048554033 cites W1972172743 @default.
• W3048554033 cites W1982737016 @default.
• W3048554033 cites W1986888030 @default.
• W3048554033 cites W1988511384 @default.
• W3048554033 cites W1995845694 @default.
• W3048554033 cites W1997230577 @default.
• W3048554033 cites W1997266537 @default.
• W3048554033 cites W2000227619 @default.
• W3048554033 cites W2001551367 @default.
• W3048554033 cites W2001962744 @default.
• W3048554033 cites W2004738537 @default.
• W3048554033 cites W2030447176 @default.
• W3048554033 cites W2048089107 @default.
• W3048554033 cites W2071402675 @default.
• W3048554033 cites W2079538614 @default.
• W3048554033 cites W2084224443 @default.
• W3048554033 cites W2096510364 @default.
• W3048554033 cites W2159359874 @default.
• W3048554033 cites W2164804809 @default.
• W3048554033 cites W2210630805 @default.
• W3048554033 cites W2228026407 @default.
• W3048554033 cites W2266291303 @default.
• W3048554033 cites W2337004120 @default.
• W3048554033 cites W2529935033 @default.
• W3048554033 cites W2597733778 @default.
• W3048554033 cites W2658590342 @default.
• W3048554033 cites W2891926296 @default.
• W3048554033 cites W2900292386 @default.
• W3048554033 cites W2943076377 @default.
• W3048554033 cites W2965214704 @default.
• W3048554033 cites W2969631385 @default.
• W3048554033 cites W3142139071 @default.
• W3048554033 doi "https://doi.org/10.1111/jdv.16858" @default.
• W3048554033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32779249" @default.
• W3048554033 hasPublicationYear "2020" @default.
• W3048554033 type Work @default.
• W3048554033 sameAs 3048554033 @default.
• W3048554033 citedByCount "9" @default.
• W3048554033 countsByYear W30485540332020 @default.
• W3048554033 countsByYear W30485540332021 @default.
• W3048554033 countsByYear W30485540332023 @default.
• W3048554033 crossrefType "journal-article" @default.
• W3048554033 hasAuthorship W3048554033A5035044854 @default.
• W3048554033 hasAuthorship W3048554033A5047001800 @default.
• W3048554033 hasBestOaLocation W30485540332 @default.
• W3048554033 hasConcept C126322002 @default.
• W3048554033 hasConcept C141071460 @default.
• W3048554033 hasConcept C167135981 @default.
• W3048554033 hasConcept C197934379 @default.
• W3048554033 hasConcept C2776715498 @default.
• W3048554033 hasConcept C2776760755 @default.
• W3048554033 hasConcept C2778397455 @default.
• W3048554033 hasConcept C2778720950 @default.
• W3048554033 hasConcept C2779134260 @default.
• W3048554033 hasConcept C2781059491 @default.
• W3048554033 hasConcept C71924100 @default.
• W3048554033 hasConceptScore W3048554033C126322002 @default.
• W3048554033 hasConceptScore W3048554033C141071460 @default.
• W3048554033 hasConceptScore W3048554033C167135981 @default.
• W3048554033 hasConceptScore W3048554033C197934379 @default.
• W3048554033 hasConceptScore W3048554033C2776715498 @default.
• W3048554033 hasConceptScore W3048554033C2776760755 @default.
• W3048554033 hasConceptScore W3048554033C2778397455 @default.
• W3048554033 hasConceptScore W3048554033C2778720950 @default.
• W3048554033 hasConceptScore W3048554033C2779134260 @default.
• W3048554033 hasConceptScore W3048554033C2781059491 @default.
• W3048554033 hasConceptScore W3048554033C71924100 @default.
• W3048554033 hasIssue "11" @default.
• W3048554033 hasLocation W30485540331 @default.
• W3048554033 hasLocation W30485540332 @default.
• W3048554033 hasOpenAccess W3048554033 @default.
• W3048554033 hasPrimaryLocation W30485540331 @default.
• W3048554033 hasRelatedWork W1600551280 @default.
• W3048554033 hasRelatedWork W1989394588 @default.
• W3048554033 hasRelatedWork W2003277956 @default.
• W3048554033 hasRelatedWork W2005658686 @default.
• W3048554033 hasRelatedWork W2057366572 @default.
• W3048554033 hasRelatedWork W2067868355 @default.
• W3048554033 hasRelatedWork W2152841871 @default.
• W3048554033 hasRelatedWork W2413285244 @default.
• W3048554033 hasRelatedWork W374874850 @default.
• W3048554033 hasRelatedWork W4242949664 @default.
• W3048554033 hasVolume "34" @default.
• W3048554033 isParatext "false" @default.
• W3048554033 isRetracted "false" @default.
• W3048554033 magId "3048554033" @default.
• W3048554033 workType "article" @default.